In some embodiments, the formulations or composition described herein have a pH and osmolarity as described herein, and have a concentration of active pharmaceutical ingredient between about 0.1-about 70 mg/mL, between about 1 mg-about 70 mg/mL, between about 1 mg-about 50 mg/mL, between about 1 mg/mL and about 20 mg/mL, between about 1 mg/mL to about 10 mg/mL, between about 1 mg/mL to about 5 mg/mL, or between about 0.5 mg/mL to about 5 mg/mL of the active agent by volume of the formulation or composition
Es gibt Hinweise darauf, dass Kupferpeptide Vorgnge untersttzen knnen, die die Stabilitt und Funktion der Hautbarriere verbessern
Dutt S, Hamza I, Bartnikas TB
Some literature suggests stability up to 60 days
Its neuroprotective properties calm overactive neural circuits without sedation, making it easier to transition into sleep naturally
For over 2,000 years, from Cleopatra to the Queen of Sheba, people have traveled to the Dead Sea for its healing properties